Morphogenesis
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10500 University Center Dr Ste 110, Tamp...Phone Number
(813) 875-6600Website
www.morphogenesis-inc.comRevenue
$18.5 MillionIndustry
About Morphogenesis
TuHURA Biosciences, Inc. specializes in developing innovative immune therapies, including their flagship product IMMUNE FX (IFX), an innate immune agonist, and bi-specific immune modulating antibody drug conjugates (ADCs) like TBS-2025. The company is focused on advancing its clinical pipeline, which includes the IFX-2.0 Phase 3 registration trial. TuHURA aims to serve clients in the biopharmaceutical sector, particularly those seeking novel treatments for immune-related conditions. With a commitment to scientific research and development, TuHURA is positioned to make significant contributions to the field of immunotherapy.Explore more
SIC Code 87,873NAICS Code 54,541Show moreMorphogenesis Org Chart
Compare Similar Companies to Morphogenesis
Compare insights from companies similar to Morphogenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Morphogenesis Tech Stack
A closer look at the technologies used by Morphogenesis
Top Business Services Companies
Frequently Asked Questions Regarding Morphogenesis
Sign Up For FreeTo access detailed company insights
TuHURA Biosciences, Inc. specializes in developing innovative immune therapies, including their flagship product IMMUNE FX (IFX), an innate immune agonist, and bi-specific immune modulating antibody drug conjugates (ADCs) like TBS-2025. The company is focused on advancing its clinical pipeline, which includes the IFX-2.0 Phase 3 registration trial.... Read More